✦ LIBER ✦

Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer

✍ Scribed by M. Jalving; J. J. Koornstra; S. de Jong; E. G. E. de Vries; J. H. Kleibeuker

Book ID: 108603961
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 301 KB
Volume: 21
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2005.02335.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The potential of non-steroidal anti-infl

The potential of non-steroidal anti-inflammatory drugs (NSAIDs) for colorectal cancer prevention

✍ Monica M. Bertagnolli 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB

Induced apoptosis in the prevention of c

Induced apoptosis in the prevention of colorectal cancer by non-steroidal anti-inflammatory drugs

✍ D. J. E. Elder; C. Paraskeva 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 129 KB

Chemopreventive Effects of Non-steroidal

Chemopreventive Effects of Non-steroidal Anti-inflammatory Drugs in Early Neoplasm of Experimental Colorectal Cancer: an Apoptosome Study

✍ Vivek Vaish; Lalita Tanwar; Jasmeet Kaur; Sankar Nath Sanyal 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 627 KB

Issues in the Treatment of Ankylosing Sp

Issues in the Treatment of Ankylosing Spondylitis with Non-Steroidal Anti-Inflammatory Drugs

✍ Sjef van der Linden 📂 Article 📅 2008 🏛 Springer Vienna 🌐 German ⚖ 107 KB

Non steroidal anti-inflammatory drugs mo

Non steroidal anti-inflammatory drugs modulate the physicochemical properties of plasma membrane in experimental colorectal cancer: a fluorescence spectroscopic study

✍ Vivek Vaish; Sankar Nath Sanyal 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 707 KB

Distal bowel selectivity in the chemopre

Distal bowel selectivity in the chemoprevention of experimental colon carcinogenesis by the non-steroidal anti-inflammatory drug nabumetone

✍ Hemant K. Roy; William J. Karolski; Anne Ratashak 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 225 KB

Use of non-steroidal anti-inflammatory drugs (NSAIDs) for chemoprevention of colon cancer has been hindered by their potential gastro-intestinal toxicity. Nabumetone, which is approximately 10 to 36 times safer than conventional NSAIDs, was evaluated in 2 models of experimental colon carcinogenesis.